Stocks to watch: Shares of firms like HCLTech, Infosys, Tata Motors, Paytm, Maruti, Religare, and others will be in focus on Thursday’s trade.
Stocks To Watch On October 13: GIFT Nifty on the NSE IX traded 18 points, or 0.09 per cent, higher at 19,693, signaling that Dalal Street was headed for positive start on Friday. Here’s a slew of stocks that will be in focus today for various reasons.
Read More: Stock Market Updates: Sensex In Red, Nifty Above 19,800; HCL Tech, Infosys Trade Lower
HCLTech: The company has revised its FY24 revenue guidance to 5-6 per cent in constant currency terms from the earlier estimate of 6-8 per cent.
HCLTech reported a 9 per cent YoY increase in its net profit to Rs 3,833 crore.
IDBI Bank: The RBI is expected to accelerate a key process of vetting IDBI Bank’s potential buyers and complete it by October end in what would speed upits divestment process, reported Reuters.
Religare Enterprises: The market regulator Sebi is studying the Burman family’s open offer to acquire additional 26 per cent in Religare Enterprises and has sought additional information from the company, a news report stated.
Read More: Plaza Wires Limited IPO registers strong debut on BSE and NSE
Tata Motors: Jaguar Land Rover (JLR) India reported sales of 2,356 units for April-September, from around 1,194 units in the same period last year.
Maruti Suzuki: The company that its board will meet on October 17 to consider issuing preference shares to parent Suzuki Motor Corp SMC instead of a cash consideration to acquire Suzuki Motor Gujarat.
Paytm: The RBI has imposed a monetary penalty of Rs 5.39 crore on Paytm Payments Bank for violating Know Your Customer norms, among others.
Mphasis: The company’s arm will acquire US-based Sonnick Partners for $132.5 million. Sonnick Partners (Silverline) is a digital transformation consultancy & salesforce partner.
Read More: Infosys announces interim dividend of Rs 18 per share — check record date and other details
Dr Reddy’s: The US FDA has issued the company Form 483 with nine observations for its Bachupally unit in Hyderabad.
Panacea Biotec: The US FDA issued Form 483 with nine observations for its Baddi unit.
Lupin: The company has received US FDA approval for the generic equivalent of Xywav Oral Solution, made by Ireland’s Jazz Pharmaceuticals.
IRB Infra Trust: The company has executed definitive agreements to implement the Samakhiyali Santalpur BOT project in Gujarat. The trust will acquire a 99.96 per cent stake in STPL for a total consideration of Rs 116.2 crore. The total project cost is Rs 2,092 crore.
DISCLAIMER:Disclaimer: The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.
